 |
 
|
|
Post-marketing research takes many forms, and is important in clarifying safety and efficacy questions for marketed drugs. This research can consist of phase IV studies, which are sometimes requested by the FDA as a condition of drug approval, and other times initiated by pharmaceutical companies or by academic researchers. Other post-marketing research can focus on individual drugs or an entire class of drugs, and can take the form of a consensus development conference or retrospective database research.
Best Practice is uniquely positioned to help companies develop and implement phase IV studies and other post-marketing research, whether recommended by the Agency or initiated by industry.
Learn more:
 Phase IV Clinical Studies
Retrospective Database Analysis Projects
|
|
|
|
